Loading market data...
Thursday, July 9, 2026
Back to HomeKorea StockPremiumAll Hanmi Science coverage

Hanmi Science (008930.KS) Q1 2026: Net Profit Surges 73%, Ownership Battle Narrows to 5.8%

By MinJeKim0 views
Share
Hanmi Science (008930.KS) Q1 2026: Net Profit Surges 73%, Ownership Battle Narrows to 5.8%

Hanmi Science (008930.KS) Q1 2026: Net Profit Surges 73%, Ownership Battle Narrows to 5.8%

The headline earnings jump is real but heavily distorted — remove a one-time disposal gain and underlying profit growth is closer to 20%; the genuine story is a control contest over ₩895.7 billion in equity-method investments that will determine how wide or narrow the holding company's discount to NAV remains.

Source: Quarterly Report (54th Fiscal Year, Q1) — Filed April 2026 with DART | Consolidated Financial Statements | Unit: ₩ billions

Unlimited Korean-market analysis, $9.99/month

Hanmi Science (008930.KS) Q1 2026: Net Profit Surges 73%, Ownership Battle Narrows to 5.8%

This article became available on July 9, 2026. Subscribe to read in full, or wait until October 7, 2026 when it becomes free.

Cancel anytime. Full refund within 7 days.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

Free weekly briefing

The Korean market week, in one email

Every Saturday: the week's key KOSPI & KOSDAQ stories, earnings and foreign flows — picked from our daily coverage. Free, no card required.

Want it every morning before the open? LineVest Daily — $2.99/mo →

Free · every Saturday · unsubscribe anytime

This company

Full report on Hanmi Science

We read Hanmi Science's latest DART filing in full — financials under K-IFRS, governance, and what it means for the stock. PDF in your inbox within 3 hours.

$12 · one-time

Get the Hanmi Science report
Every name you watch

Follow the whole market

Reading several Korean stocks a week? Read every analysis article the moment it publishes — full daily KOSPI & KOSDAQ coverage plus the 90-day archive.

$9.99 · monthly

Subscribe

Independent journalism based on primary DART filings — not investment advice. No brokerage affiliation.